![NHS](/sites/default/files/styles/large/public/2024-03/NHS.jpg?itok=C3a5hclJ)
Dissatisfaction with NHS ‘at record high’
Newsletters and Deep Dive digital magazine
11-12 November 2024 in London, UK
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
At LSX in Boston last month, editor-in-chief Jonah Comstock caught up with Dr Tadaaki Taniguchi, chief medical officer at Astellas Pharmaceuticals to talk a bit about the company and some r
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
Excitement for mRNA therapeutics continues, as RNA technologies are awarded the Nobel Prize for the second year running.
Imagine the difference it would make if everyone in your organisation had firsthand experience of living with one of the conditions you help treat. What insights would you gain?